000 01313 a2200325 4500
005 20250517134601.0
264 0 _c20181024
008 201810s 0 0 cze d
022 _a0862-495X
024 7 _a10.14735/amko20163S39
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKrásenská, M
245 0 0 _a[Treatment with Aromatase Inhibitors in Postmenopausal Women with Breast Cancer and the Possibility of Influencing Side Effects].
_h[electronic resource]
260 _bKlinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
_c2016
300 _aS39-49 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents, Hormonal
_xtherapeutic use
650 0 4 _aAromatase Inhibitors
_xadverse effects
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aEstrogen Receptor Modulators
_xtherapeutic use
650 0 4 _aEstrogens
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNeoadjuvant Therapy
650 0 4 _aNeoplasms, Hormone-Dependent
_xdrug therapy
650 0 4 _aPostmenopause
650 0 4 _aTamoxifen
773 0 _tKlinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
_gvol. 29 Suppl 3
_gp. S39-49
856 4 0 _uhttps://doi.org/10.14735/amko20163S39
_zAvailable from publisher's website
999 _c26814475
_d26814475